Round Rock Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $399K | Buy |
760
+396
| +109% | +$208K | 0.07% | 152 |
|
|
2025
Q1 | $231K | Buy |
364
+4
| +1% | +$2.54K | 0.04% | 192 |
|
|
2024
Q4 | $256K | Hold |
360
| – | – | 0.05% | 179 |
|
|
2024
Q3 | $378K | Hold |
360
| – | – | 0.09% | 130 |
|
|
2024
Q2 | $378K | Sell |
360
-8
| -2% | -$8.41K | 0.09% | 126 |
|
|
2024
Q1 | $354K | Sell |
368
-92
| -20% | -$88.5K | 0.08% | 145 |
|
|
2023
Q4 | $404K | Hold |
460
| – | – | 0.1% | 126 |
|
|
2023
Q3 | $379K | Hold |
460
| – | – | 0.14% | 96 |
|
|
2023
Q2 | $331K | Buy |
460
+100
| +28% | +$71.9K | 0.12% | 109 |
|
|
2023
Q1 | $296K | Hold |
360
| – | – | 0.11% | 119 |
|
|
2022
Q4 | $260K | Sell |
360
-10
| -3% | -$7.22K | 0.11% | 128 |
|
|
2022
Q3 | $255K | Hold |
370
| – | – | 0.12% | 121 |
|
|
2022
Q2 | $219K | Buy |
+370
| New | +$219K | 0.1% | 129 |
|